Enrofloxacin, Silver Sulfadiazine

24 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

0.0%

Death Rate

Active Ingredients

Enrofloxacin, Silver Sulfadiazine

Administration Routes

UnknownAuricular (Otic)

Species Affected

Unknown 15

Dog 6

Cat 3

Most Affected Breeds

Unknown 15

Domestic (unspecified) 3

Retriever - Labrador 2

Shepherd Dog - German 1

Poodle (unspecified) 1

Terrier - Yorkshire 1

Spaniel (unspecified) 1

Most Reported Reactions

Applicator, Abnormal 6

Vials, Leaking 3

Caps, Abnormal 3

Vomiting 2

Pinnal erythema 2

Vials, Abnormal 2

Product label issues 1

Containers, Abnormal 1

Systemic disorder NOS 1

Urination 1

Nystagmus 1

Application site erythema 1

Outcome Breakdown

Ongoing

2 (66.7%)

Outcome Unknown

1 (33.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.